FDA Device Recalls

Recalls /

#153263

Product

MEVATRON MD-2, MEVATRON MDX-2 and MEVATRON ME, accelerator, Linear, Medical The intended use of the SIEMENS branded PRIMUS family of linear accelerator systems is to deliver x-ray radiation for therapeutic treatment of cancer

FDA product code
IYEAccelerator, Linear, Medical
Device class
Class 2
Medical specialty
Radiology
510(k) numbers
K882729
Affected lot / code info
Device Model Number 9401654, 9401746, 8490005 Serial numbers: 3009 2958 2863 2972 2646 3079 2516 2962 3055 1452 2702 2125 3066 2689 2228 2564 2507 1904 3075 2375 3013 3068 2596 3025 3049 2965 2045 3084 2855 2906 2292 2384 2067 2818 3089

Why it was recalled

Siemens became aware of a defective weld seam at overhead suspensions. Due to this defect it is possible for the weld seam to break and to cause the overhead suspension to fall down. This can lead to a severe injury to a patient or any other person.

Root cause (FDA determination)

Under Investigation by firm

Action the firm took

Siemens sent a Customer Safety Advisory Notice (CSAN) dated February 7, 2017, to affected customers to inform them of a planned hardware update regarding the mechanics of the overhead suspension of their Digital Linear Accelerator. The notice also explained the actions Siemens is taking to perform the necessary fix at the affected sites. Customers were advised to notify anyone at their organization that should be aware of this information. Also, the safety notice should be forwarded to the new owner and Siemens also requested they be informed of the identity of the device's new owner where possible. Customers with questions were instructed to call 1-800-888-7436. For questions regarding this recall call 610-448-6478.

Recalling firm

Firm
Siemens Medical Solutions USA, Inc
Address
40 Liberty Blvd, Malvern, Pennsylvania 19355-1418

Distribution

Distribution pattern
Nationwide Distribution

Timeline

Recall initiated
2017-01-25
Terminated
2017-10-06
Status

Source: openFDA Device Recall endpoint. Recall record ID #153263. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.